$ORC
Orchid Island Capital, Inc.

2020 Q3 Form 10-Q Financial Statement

#000151862120000060 Filed on July 31, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2020 Q2 2019 Q2
Revenue $27.22M $27.26M $36.46M
YoY Change -24.18% -25.23% -5.53%
Cost Of Revenue $3.300M $5.750M $23.76M
YoY Change -86.11% -75.8% 30.62%
Gross Profit $29.67M $50.26M $5.030M
YoY Change -507.0% 899.2% 88.39%
Gross Profit Margin 108.99% 184.39% 13.8%
Selling, General & Admin $2.849M $2.756M $2.821M
YoY Change 8.24% -2.3% -3.75%
% of Gross Profit 9.6% 5.48% 56.08%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $2.849M $2.756M $2.821M
YoY Change 8.24% -2.3% -3.75%
Operating Profit $26.82M $47.50M $2.209M
YoY Change -370.32% 2050.48% -946.36%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.220M $1.140M $1.168M
YoY Change 45.07% -2.4% 21.16%
Pretax Income $28.08M $48.77M $3.530M
YoY Change -431.13% 1281.59% 161.48%
Income Tax
% Of Pretax Income
Net Earnings $28.08M $48.77M $3.533M
YoY Change -431.2% 1280.47% 162.48%
Net Earnings / Revenue 103.13% 178.93% 9.69%
Basic Earnings Per Share $0.42 $0.74 $0.07
Diluted Earnings Per Share $0.42 $0.73 $0.07
COMMON SHARES
Basic Shares Outstanding 66.22M shares 66.24M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $199.8M $175.3M $135.6M
YoY Change 35.55% 29.28% -1.67%
Cash & Equivalents $199.8M $175.3M $181.1M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $0.00 $700.0K $0.00
Other Receivables $10.40M $10.30M $13.90M
Total Short-Term Assets $210.2M $186.3M $149.5M
YoY Change -43.69% 24.62% -2.1%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.540B $3.445B $3.527B
YoY Change -7.34% -2.35% -4.4%
Other Assets $47.50M $60.80M $32.70M
YoY Change 75.28% 85.93% 41.56%
Total Long-Term Assets $3.603B $3.514B $3.577B
YoY Change -7.15% -1.77% -4.74%
TOTAL ASSETS
Total Short-Term Assets $210.2M $186.3M $149.5M
Total Long-Term Assets $3.603B $3.514B $3.577B
Total Assets $3.813B $3.700B $3.727B
YoY Change -10.35% -0.71% -4.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $600.0K $600.0K $600.0K
YoY Change 0.0% 0.0% -14.29%
Accrued Expenses $800.0K $700.0K $10.10M
YoY Change -93.28% -93.07% 40.28%
Deferred Revenue
YoY Change
Short-Term Debt $3.281B $3.315B $3.330B
YoY Change -13.97% -0.45% -3.49%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.401B $3.320B $3.345B
YoY Change -11.24% -0.75% -3.41%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $35.40M $34.90M $22.70M
YoY Change 18.79% 53.74% -37.64%
Total Long-Term Liabilities $35.40M $34.90M $22.70M
YoY Change 18.79% 53.74% -37.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.401B $3.320B $3.345B
Total Long-Term Liabilities $35.40M $34.90M $22.70M
Total Liabilities $3.436B $3.354B $3.367B
YoY Change -11.01% -0.38% -3.76%
SHAREHOLDERS EQUITY
Retained Earnings -$34.47M -$62.55M -$30.26M
YoY Change -11.0% 106.73% 101.31%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $376.7M $346.0M $359.7M
YoY Change
Total Liabilities & Shareholders Equity $3.813B $3.700B $3.727B
YoY Change -10.35% -0.71% -4.64%

Cashflow Statement

Concept 2020 Q3 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income $28.08M $48.77M $3.533M
YoY Change -431.2% 1280.47% 162.48%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $18.82M $19.16M $17.16M
YoY Change 113.62% 11.66% -52.15%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$117.6M -$336.4M -$457.8M
YoY Change -77.11% -26.51% -385.2%
Cash From Investing Activities -$117.6M -$336.4M -$457.8M
YoY Change -77.11% -26.51% -385.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 110.1M 351.8M 478.8M
YoY Change -79.07% -26.52% -350.2%
NET CHANGE
Cash From Operating Activities 18.82M 19.16M 17.16M
Cash From Investing Activities -117.6M -336.4M -457.8M
Cash From Financing Activities 110.1M 351.8M 478.8M
Net Change In Cash 11.32M 34.58M 38.16M
YoY Change -46.4% -9.38% 661.68%
FREE CASH FLOW
Cash From Operating Activities $18.82M $19.16M $17.16M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
600000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.1 pure
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
600000 USD
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
dei Amendment Flag
AmendmentFlag
false
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
4000000 shares
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-74822000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-43257000 USD
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
66220664 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63061781 shares
CY2019Q4 us-gaap Other Payables To Broker Dealers And Clearing Organizations
OtherPayablesToBrokerDealersAndClearingOrganizations
0 USD
CY2020Q2 us-gaap Other Payables To Broker Dealers And Clearing Organizations
OtherPayablesToBrokerDealersAndClearingOrganizations
0 USD
CY2019Q1 orc Securities Acquisitions Settled In Later Period
SecuritiesAcquisitionsSettledInLaterPeriod
0 USD
CY2020Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
0 USD
CY2019Q2 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
3.42
dei Entity Central Index Key
EntityCentralIndexKey
0001518621
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
66220664 shares
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Type
DocumentType
10-Q
dei Document Transition Report
DocumentTransitionReport
false
dei City Area Code
CityAreaCode
772
CY2020Q2 us-gaap Interest Receivable
InterestReceivable
10241000 USD
CY2019Q4 us-gaap Interest Receivable
InterestReceivable
12404000 USD
CY2020Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
8231000 USD
dei Local Phone Number
LocalPhoneNumber
231-1400
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
dei Trading Symbol
TradingSymbol
ORC
dei Security Exchange Name
SecurityExchangeName
NYSE
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
0 USD
dei Entity File Number
EntityFileNumber
001-35236
dei Entity Registrant Name
EntityRegistrantName
Orchid Island Capital, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-3269228
dei Entity Address Address Line1
EntityAddressAddressLine1
3305 Flamingo Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Vero Beach
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32963
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q2 us-gaap Financial Instruments Owned And Pledged As Collateral At Fair Value
FinancialInstrumentsOwnedAndPledgedAsCollateralAtFairValue
3294042000 USD
CY2019Q4 us-gaap Financial Instruments Owned And Pledged As Collateral At Fair Value
FinancialInstrumentsOwnedAndPledgedAsCollateralAtFairValue
3584354000 USD
CY2020Q2 us-gaap Financial Instruments Owned And Not Pledged At Fair Value
FinancialInstrumentsOwnedAndNotPledgedAtFairValue
10719000 USD
CY2019Q4 us-gaap Financial Instruments Owned And Not Pledged At Fair Value
FinancialInstrumentsOwnedAndNotPledgedAtFairValue
6567000 USD
CY2020Q2 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
3304761000 USD
CY2019Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
3590921000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
175269000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
193770000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
60761000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
84885000 USD
CY2020Q2 us-gaap Other Receivables From Broker Dealers And Clearing Organizations
OtherReceivablesFromBrokerDealersAndClearingOrganizations
727000 USD
CY2019Q4 us-gaap Other Receivables From Broker Dealers And Clearing Organizations
OtherReceivablesFromBrokerDealersAndClearingOrganizations
0 USD
CY2020Q2 orc Reverse Repurchase Agreements
ReverseRepurchaseAgreements
139738000 USD
CY2019Q4 orc Reverse Repurchase Agreements
ReverseRepurchaseAgreements
0 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
680000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
100000 USD
CY2020Q2 us-gaap Assets
Assets
3700408000 USD
CY2019Q4 us-gaap Assets
Assets
3882080000 USD
CY2020Q2 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
3174739000 USD
CY2019Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
3448106000 USD
CY2020Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
3642000 USD
CY2019Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
5045000 USD
CY2020Q2 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
33229000 USD
CY2019Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
20658000 USD
CY2020Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
706000 USD
CY2019Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
11101000 USD
CY2020Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
569000 USD
CY2019Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
622000 USD
CY2020Q2 us-gaap Securities Borrowed Liability
SecuritiesBorrowedLiability
139843000 USD
CY2019Q4 us-gaap Securities Borrowed Liability
SecuritiesBorrowedLiability
0 USD
CY2020Q2 us-gaap Other Liabilities
OtherLiabilities
1712000 USD
CY2019Q4 us-gaap Other Liabilities
OtherLiabilities
1041000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
3354440000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
3486573000 USD
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
66220664 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63061781 shares
CY2020Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
662000 USD
CY2019Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
631000 USD
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
407855000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
414998000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-62549000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20122000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
345968000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
395507000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3700408000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3882080000 USD
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
62929000 USD
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
68888000 USD
CY2020Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
27258000 USD
CY2019Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
36455000 USD
us-gaap Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
21002000 USD
us-gaap Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
41323000 USD
CY2020Q2 us-gaap Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
4479000 USD
CY2019Q2 us-gaap Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
22431000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
41927000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
27565000 USD
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
22779000 USD
CY2019Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
14024000 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-25020000 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
355000 USD
CY2020Q2 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
3360000 USD
CY2019Q2 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
112000 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
37272000 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
44547000 USD
CY2020Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
34240000 USD
CY2020Q2 us-gaap Management Fee Expense
ManagementFeeExpense
1268000 USD
CY2019Q2 us-gaap Management Fee Expense
ManagementFeeExpense
1326000 USD
us-gaap Cost Of Goods And Services Sold Overhead
CostOfGoodsAndServicesSoldOverhead
695000 USD
CY2020Q2 orc Direct Reit Operating Expenses
DirectReitOperatingExpenses
240000 USD
CY2019Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
26506000 USD
us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
-91709000 USD
us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
-53320000 USD
CY2020Q2 us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
-8851000 USD
CY2019Q2 us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
-34288000 USD
orc Net Portfolio Income
NetPortfolioIncome
-37530000 USD
CY2019Q2 orc Direct Reit Operating Expenses
DirectReitOperatingExpenses
285000 USD
orc Net Portfolio Income
NetPortfolioIncome
19147000 USD
CY2020Q2 orc Net Portfolio Income
NetPortfolioIncome
51528000 USD
CY2019Q2 orc Net Portfolio Income
NetPortfolioIncome
6354000 USD
us-gaap Management Fee Expense
ManagementFeeExpense
2645000 USD
us-gaap Management Fee Expense
ManagementFeeExpense
2611000 USD
orc Direct Reit Operating Expenses
DirectReitOperatingExpenses
660000 USD
us-gaap Cost Of Goods And Services Sold Overhead
CostOfGoodsAndServicesSoldOverhead
650000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold Overhead
CostOfGoodsAndServicesSoldOverhead
348000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold Overhead
CostOfGoodsAndServicesSoldOverhead
327000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
-275000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
-226000 USD
CY2020Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
161000 USD
CY2019Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
182000 USD
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
508000 USD
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
490000 USD
CY2020Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
248000 USD
CY2019Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
237000 USD
us-gaap Professional Fees
ProfessionalFees
601000 USD
us-gaap Professional Fees
ProfessionalFees
665000 USD
CY2020Q2 us-gaap Professional Fees
ProfessionalFees
346000 USD
CY2019Q2 us-gaap Professional Fees
ProfessionalFees
364000 USD
orc Direct Reit Operating Expenses
DirectReitOperatingExpenses
446000 USD
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
277000 USD
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
167000 USD
CY2020Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
145000 USD
CY2019Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
100000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4897000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5017000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2756000 USD
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2821000 USD
us-gaap Profit Loss
ProfitLoss
-42427000 USD
us-gaap Profit Loss
ProfitLoss
14130000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
48772000 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
3533000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.74
us-gaap Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
12252000 USD
us-gaap Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
44902000 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-2163000 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
624000 USD
CY2020Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
4000 shares
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
359658000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
395507000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-91199000 USD
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
-15670000 USD
CY2020Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3171000 shares
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
19447000 USD
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
65408722 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
50762883 shares
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
66310219 shares
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
52600758 shares
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.405
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.480
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.165
CY2019Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.240
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49132000 shares
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
336079000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
10597000 USD
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
-11822000 USD
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8503000 USD
CY2019Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
7000 shares
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-6000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
87000 USD
CY2019Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-3024000 USD
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49938000 shares
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
340414000 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
3533000 USD
CY2019Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
-12859000 USD
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
28495000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
43000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
32000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
59000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
308144000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
48772000 USD
CY2020Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
-10935000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
55000 USD
CY2020Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-68000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
345968000 USD
us-gaap Profit Loss
ProfitLoss
-42427000 USD
us-gaap Profit Loss
ProfitLoss
14130000 USD
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
114000 USD
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
158000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
580000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-162000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-10395000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
3609000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
671000 USD
orc Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Trading
ProceedsFromSaleOfMortgageBackedSecuritiesMbsCategorizedAsTrading
1689747000 USD
orc Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Categorized As Trading
ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesCategorizedAsTrading
260834000 USD
orc Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Categorized As Trading
ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesCategorizedAsTrading
229633000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-116000 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-53000 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-100000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
12063000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
15574000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1985756000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
2164094000 USD
orc Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Trading
ProceedsFromSaleOfMortgageBackedSecuritiesMbsCategorizedAsTrading
2023334000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
181093000 USD
us-gaap Interest Paid Net
InterestPaidNet
31397000 USD
us-gaap Interest Paid Net
InterestPaidNet
37713000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
139712000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
0 USD
us-gaap Proceeds From Payments For Securities Purchased Under Agreements To Resell
ProceedsFromPaymentsForSecuritiesPurchasedUnderAgreementsToResell
-139738000 USD
us-gaap Proceeds From Payments For Securities Purchased Under Agreements To Resell
ProceedsFromPaymentsForSecuritiesPurchasedUnderAgreementsToResell
0 USD
orc Proceeds From Net Tba Settlements
ProceedsFromNetTbaSettlements
-6888000 USD
orc Proceeds From Net Tba Settlements
ProceedsFromNetTbaSettlements
-10559000 USD
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
64190000 USD
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
19649000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
227308000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-274922000 USD
orc Proceeds From Securities Sold Under Agreements To Repurchase
ProceedsFromSecuritiesSoldUnderAgreementsToRepurchase
20879112000 USD
orc Proceeds From Securities Sold Under Agreements To Repurchase
ProceedsFromSecuritiesSoldUnderAgreementsToRepurchase
22265665000 USD
orc Payments For Securities Sold Under Agreements To Repurchase
PaymentsForSecuritiesSoldUnderAgreementsToRepurchase
21152479000 USD
orc Payments For Securities Sold Under Agreements To Repurchase
PaymentsForSecuritiesSoldUnderAgreementsToRepurchase
21961190000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
28008000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
24271000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
19447000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
36998000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
68000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3024000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-281996000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
314178000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-42625000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
54830000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
278655000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
126263000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
236030000 USD
us-gaap Use Of Estimates
UseOfEstimates
<span style="font-family: 'Arial Narrow', 'sans-serif'; font-size: 11.00pt; letter-spacing: -0.10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The significant estimates affecting the accompanying financial statements are the fair values of RMBS and derivatives. Management believes the estimates and assumptions underlying the financial statements are reasonable based on the information available as of June 30, 2020; however, uncertainty over the ultimate impact that COVID-19 will have on the global economy generally, and on Orchid’s business in particular, makes any estimates and assumptions as of June 30, 2020 inherently less certain than they would be absent the current and potential impacts of COVID-19.</span>
CY2019Q4 us-gaap Securities Sold Under Agreements To Repurchase Fair Value Of Collateral
SecuritiesSoldUnderAgreementsToRepurchaseFairValueOfCollateral
3596721000 USD
CY2019Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
3448106000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
175269000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
193770000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
60761000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
84885000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
236030000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
278655000 USD
CY2020Q2 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
3304761000 USD
CY2019Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
3590921000 USD
CY2020Q2 us-gaap Securities Sold Under Agreements To Repurchase Fair Value Of Collateral
SecuritiesSoldUnderAgreementsToRepurchaseFairValueOfCollateral
3304465000 USD
CY2020Q2 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
3174739000 USD
CY2020Q2 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0027 pure
CY2020Q2 orc Gross Amount Of Financial Instruments Posted Not Offset In Balance Sheet
GrossAmountOfFinancialInstrumentsPostedNotOffsetInBalanceSheet
-3139130000 USD
CY2020Q2 orc Gross Amounts Of Cash Posted Not Offset In Balance Sheet
GrossAmountsOfCashPostedNotOffsetInBalanceSheet
-60106000 USD
CY2020Q2 orc Net Amount Of Liabilities
NetAmountOfLiabilities
8732000 USD
CY2019Q4 orc Gross Amount Of Recognized Liabilties
GrossAmountOfRecognizedLiabilties
3468764000 USD
CY2019Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0203 pure
CY2019Q4 orc Gross Amount Of Liabilties Offset In The Balance Sheet
GrossAmountOfLiabiltiesOffsetInTheBalanceSheet
0 USD
CY2019Q4 orc Net Amount Of Liabilities Presented In The Balance Sheet
NetAmountOfLiabilitiesPresentedInTheBalanceSheet
3468764000 USD
CY2019Q4 orc Gross Amount Of Financial Instruments Posted Not Offset In Balance Sheet
GrossAmountOfFinancialInstrumentsPostedNotOffsetInBalanceSheet
-3382255000 USD
CY2020Q2 us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
-8851000 USD
CY2019Q2 us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
-34288000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
60761000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
84885000 USD
CY2020Q2 orc Assets Pledged To Counterparties
AssetsPledgedToCounterparties
3364930000 USD
CY2019Q4 orc Assets Pledged To Counterparties
AssetsPledgedToCounterparties
3681606000 USD
CY2020Q2 orc Securities Pledged By Counterparties
SecuritiesPledgedByCounterparties
152015000 USD
CY2019Q4 orc Securities Pledged By Counterparties
SecuritiesPledgedByCounterparties
1418000 USD
CY2020Q2 orc Gross Amount Of Recognized Assets
GrossAmountOfRecognizedAssets
147969000 USD
CY2020Q2 orc Gross Amount Of Assets Offset In The Balance Sheet
GrossAmountOfAssetsOffsetInTheBalanceSheet
0 USD
CY2020Q2 orc Net Amount Of Assets Presented In The Balance Sheet
NetAmountOfAssetsPresentedInTheBalanceSheet
147969000 USD
CY2020Q2 orc Gross Amounts Of Financial Instruments Received Not Offset In Balance Sheet
GrossAmountsOfFinancialInstrumentsReceivedNotOffsetInBalanceSheet
-140260000 USD
CY2020Q2 orc Gross Amounts Of Cash Collateral Received Not Offset In Balance Sheet
GrossAmountsOfCashCollateralReceivedNotOffsetInBalanceSheet
-406000 USD
CY2020Q2 orc Net Amount Of Assets
NetAmountOfAssets
7303000 USD
CY2020Q2 orc Gross Amount Of Recognized Liabilties
GrossAmountOfRecognizedLiabilties
3207968000 USD
CY2020Q2 orc Gross Amount Of Liabilties Offset In The Balance Sheet
GrossAmountOfLiabiltiesOffsetInTheBalanceSheet
0 USD
CY2020Q2 orc Net Amount Of Liabilities Presented In The Balance Sheet
NetAmountOfLiabilitiesPresentedInTheBalanceSheet
3207968000 USD
CY2019Q4 orc Gross Amounts Of Cash Posted Not Offset In Balance Sheet
GrossAmountsOfCashPostedNotOffsetInBalanceSheet
-83547000 USD
CY2019Q4 orc Net Amount Of Liabilities
NetAmountOfLiabilities
2962000 USD
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3170727000 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
19447000 USD
CY2019 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
14377126 shares
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
92314000 USD
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-42426000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-42426000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
14130000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
14130000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
48773000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
48773000 USD
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3533000 USD
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3533000 USD
orc Common Shares Outstanding Earnings Per Share
CommonSharesOutstandingEarningsPerShare
66221000 shares
orc Common Shares Outstanding Earnings Per Share
CommonSharesOutstandingEarningsPerShare
54283000 shares
CY2020Q2 orc Common Shares Outstanding Earnings Per Share
CommonSharesOutstandingEarningsPerShare
66221000 shares
CY2019Q2 orc Common Shares Outstanding Earnings Per Share
CommonSharesOutstandingEarningsPerShare
54283000 shares
orc Unvested Dividend Eligible Shares Outstanding Earnings Per Share
UnvestedDividendEligibleSharesOutstandingEarningsPerShare
0 shares
orc Unvested Dividend Eligible Shares Outstanding Earnings Per Share
UnvestedDividendEligibleSharesOutstandingEarningsPerShare
54000 shares
CY2020Q2 orc Unvested Dividend Eligible Shares Outstanding Earnings Per Share
UnvestedDividendEligibleSharesOutstandingEarningsPerShare
80000 shares
CY2019Q2 orc Unvested Dividend Eligible Shares Outstanding Earnings Per Share
UnvestedDividendEligibleSharesOutstandingEarningsPerShare
54000 shares
orc Effect Of Weighting
EffectOfWeighting
-812000 shares
orc Effect Of Weighting
EffectOfWeighting
-3574000 shares
CY2020Q2 orc Effect Of Weighting
EffectOfWeighting
9000 shares
CY2019Q2 orc Effect Of Weighting
EffectOfWeighting
-1736000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
65409000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
50763000 shares
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
66310000 shares
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
52601000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.74
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
80000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares

Files In Submission

Name View Source Status
0001518621-20-000060-index-headers.html Edgar Link pending
0001518621-20-000060-index.html Edgar Link pending
0001518621-20-000060.txt Edgar Link pending
0001518621-20-000060-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_000.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
orc-20200630.xsd Edgar Link pending
orc-20200630_cal.xml Edgar Link unprocessable
orc-20200630_def.xml Edgar Link unprocessable
orc-20200630_lab.xml Edgar Link unprocessable
orc-20200630_pre.xml Edgar Link unprocessable
orc10q20200630x311.htm Edgar Link pending
orc10q20200630x312.htm Edgar Link pending
orc10q20200630x321.htm Edgar Link pending
orc10q20200630x322.htm Edgar Link pending
orc2020q2.htm Edgar Link pending
orc2020q2_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending